Therefore, studies analyzing the genetic and epigenetic modulation of ABCG1 in populations of patients with hepatosteatosis or NASH will greatly help to evaluate the contribution of ABCG1 expression in NAFLD. Here, ABCG1 is linked to metabolic dysfunction-associated steatotic liver disease.